Author:
Noguchi S.,Iwasaki H.,Shiko Y.,Kawasaki Y.,Ishida Y.,Shinomiya S.,Ono Uokawa R.,Mazda Y.
Abstract
(Int J Obstet Anesth. 2023;53:103620)
Sugammadex (SGX) quickly and reliably reverses neuromuscular blockade. It also is known to bind progesterone and maintaining proper progesterone levels is critical during pregnancy, especially during the first trimester. Little is known about the impact of SGX exposure during pregnancy on pregnancy and fetal outcomes. This study aimed to compare fetal outcomes in pregnant patients who underwent nonobstetric surgery who were and were not exposed to SGX.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Pharmacology (medical),Complementary and alternative medicine,Pharmaceutical Science